Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
Ciccarese C, Iacovelli R, Buti S, Primi F, Astore S, Massari F, Ferrara MG, Palermo G, Foschi N, Iacovelli V, Rossi E, Schinzari G, Bove P, Bassi P, Bria E, Tortora G.
Ciccarese C, et al. Among authors: foschi n.
Anticancer Res. 2022 Mar;42(3):1487-1493. doi: 10.21873/anticanres.15620.
Anticancer Res. 2022.
PMID: 35220243